ACM
JAZZ icon

Argent Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Argent Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$44.7M Sell
193,207
-6,865
-3% -$1.7M 1.43% 22
2026
Q2 		$48.2M Buy
+200,072
New +$43.8M 1.52% 20

Other funds holding JAZZ

Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Perpetual Ltd
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Burney Company
Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $638M AUM 30.27% 1-Year Est. Return
CX Institutional
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
Gateway Investment Advisers
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Argent Capital Management's JAZZ Position: Q3 2026 in Review

Argent Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 3.4% in Q3 2026, selling an estimated $1.7M and leaving 193,207 shares worth $44.7M. The position accounts for 1.43% of the portfolio, ranked #22.

Argent Capital Management first reported a position in JAZZ in Q2 2026 and has held it in 2 quarters since. The position peaked at $48.2M in Q2 2026. 55 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Argent Capital Management held 193,207 shares of Jazz Pharmaceuticals worth $44.7M as of Q3 2026.
  • Argent Capital Management sold 6,865 Jazz Pharmaceuticals shares in Q3 2026, an estimated $1.7M.
  • Jazz Pharmaceuticals made up 1.43% of Argent Capital Management's portfolio in Q3 2026, its #22 holding.
  • Argent Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • Argent Capital Management's Jazz Pharmaceuticals position peaked at $48.2M in Q2 2026.
  • 55 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Argent Capital Management's 13F filing for Q3 2026, filed 5 Oct 2026.